<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114266">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01851967</url>
  </required_header>
  <id_info>
    <org_study_id>2012-P-002340</org_study_id>
    <nct_id>NCT01851967</nct_id>
  </id_info>
  <brief_title>Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans</brief_title>
  <official_title>Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate efficacy and acceptability of the Chinese language version of
      MoodGYM as a therapeutic intervention in treating symptoms of depression in community
      dwelling Chinese Americans in the Boston area.

      Hypothesis 1: Participants enrolled in MoodGYM will show a significant decrease in
      depressive symptoms after completion of the 5 modules.

      Hypothesis 2: Participants enrolled in MoodGYM will show significantly improved
      dysfunctional thinking.

      Hypothesis 3: Participants enrolled in MoodGym will rate this program as culturally
      acceptable.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2013</start_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in Center for Epidemiologic Studies Depression Scale (CES-D)</measure>
    <time_frame>Weeks 0, 6 (pre/post)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The CES-D scale is a short self-report scale designed to measure depressive symptomatology in the general population. Each of the 20 items in this instrument is assigned one value of 0, 1, 2 or 3. High scores on the CES-D indicate high levels of distress.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>MoodGYM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This study is a single-arm intervnetion. All subjects will be assigned to receive six weeks of online CBT through MoodGYM.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MoodGYM</intervention_name>
    <description>MoodGYM, a publicly-available online CBT program developed by the Centre for Mental Health Research at The Australian National University has been shown by multiple studies to be effective in reducing symptoms of depression. MoodGYM consists of five interactive modules. Participants will be asked to complete one module each week and progress through the program sequentially.</description>
    <arm_group_label>MoodGYM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resident of the US, but self-identified as Chinese origin

          -  At least 18 years of age

          -  Proficiency in Chinese, including the ability to read Chinese

          -  Access to computer and internet

          -  Scores &gt; 10 on the Chinese bilingual patient health questionnaire -9 item (PHQ-9)

        Exclusion Criteria:

          -  Current ongoing psychiatric or psychological treatment

          -  Using illicit drugs or consumption &gt; 3 standard drinks in a day

          -  Currently experiencing a psychotic illness

          -  Past or current history of schizophrenia or bipolar disorder

          -  ECT during the last year

          -  Current active suicidal or self-injurious potential necessitating immediate
             face-to-face treatment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Albert Yeung, MD, ScD</last_name>
    <phone>617-724-5138</phone>
    <email>ayeung@partners.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aya Inamori, BA</last_name>
    <phone>617-724-0586</phone>
    <email>ainamori@partners.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Massachusetts General Hospital Depression Clinical and Research Program</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angela Pisoni, BA</last_name>
      <phone>617-726-0517</phone>
      <email>apisoni@partners.org</email>
    </contact>
    <investigator>
      <last_name>Albert Yeung, MD, ScD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://moodgym.anu.edu.au/welcome/new/splash</url>
    <description>MoodGYM (English version)</description>
  </link>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 13, 2013</lastchanged_date>
  <firstreceived_date>January 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Albert Yeung</investigator_full_name>
    <investigator_title>Principle Investigator / Psychiatrist</investigator_title>
  </responsible_party>
  <keyword>Major depressive disorder</keyword>
  <keyword>Cognitive behavioral therapy</keyword>
  <keyword>Computerized CBT</keyword>
  <keyword>Online CBT</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
